Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and...

Details Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and... Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and...

A - Human Necessities

61

K

A61K 38/19 (2006.01) A61K 31/435 (2006.01) A61K 31/445 (2006.01) A61K 31/473 (2006.01) A61K 31/505 (2006.01) A61K 31/555 (2006.01) A61K 31/675 (2006.01) A61K 33/24 (2006.01) A61K 38/14 (2006.01)

Patent

CA 2136860

2136860 9324096 PCTABS00028 A new treatment schedule for administration of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and other related carboxamide anticancer drugs in which the drug is administered in a divided-dose shedule comprising two or more administrations at frequent intervals, for example every hour. Schedules to produce cyclic peaks/troughs in plasma levels are mentioned. The compounds can be used for circumventing multidrug resistance in cancers and may, for example, be used in combination with other cytotoxic drugs, especially non-topo II inhibitors. Treatment of melanoma and advanced colon cancer is included.

Affiliated with

Also associated with

Rating

Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1544601